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Table S1. Crystallographic summary for 1–3. 
 1 2 3 
Formula C13H14N3O3Re C13H15BF4N3O3Re C12H15B2F8N4O3Re 
fw, g/mol  446.47 534.29 623.10 
Temperature/K 100(2)  100(2)  100(2)  
cryst. syst. Monoclinic Monoclinic Orthorhombic 
space group  P21/c P21/n Pca21 
color Colorless Colorless Yellow 
a/Å 9.8852(5) 8.1382(10) 21.1586(9) 
b/Å 14.8057(7) 21.483(3) 7.8417(3) 
c/Å 9.5666(5) 9.4361(12) 22.8621(10) 
/°  90 90 90 
/° 104.348(2) 90.539(6) 90 
/°  90 90 90 
V/Å3 1356.47(12) 1649.7(4) 3793.3(3) 
 (calc.)/(g cm−3) 2.186 2.151 2.182 
Z 4 4 8 
no. refl. 42327 197454 118663 
no. unique refl. 7027 13825 12650 
Rint 0.0379 0.0451 0.0654 
R1a (all data) 0.0278 0.0233 0.0445 
wR2b (all data) 0.0462 0.0434 0.0888 
R1 [(I > 2)] 0.0201 0.0189 0.0386 
wR2 [(I > 2)] 0.0437 0.0422 0.0858 
GOFc 1.019 1.122 1.120 
a R1 = ||Fo − |Fc||/|Fo|. 
b wR2 = ((w(Fo
2 − Fc
2)2)/(w(Fo
2)2))1/2. c GOF =  
(w(Fo
2 − Fc
2)2/(n − p))1/2 where n is the number of data and p is the number of parameters refined.  
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Table S2. Crystallographic summary for 4 and 7. 
 4 7 
Formula C12H14BF4N4O3Re C13H17N4O4Re 
fw, g/mol  535.28 479.51 
Temperature/K 100(2)  100(2)  
cryst. syst. Monoclinic Monoclinic 
space group  P21/c P21/c 
color Orange Yellow 
a/Å 11.1053(4) 8.3732(4) 
b/Å 9.9635(3) 7.8158(4) 
c/Å 14.9378(5) 23.0017(11) 
/°  90 90 
/° 95.2430(10) 95.791(2) 
/°  90 90 
V/Å3 1645.92(9) 1497.62(13) 
 (calc.)/(g cm−3) 2.160 2.127 
Z 4 4 
no. refl. 37996 137916 
no. unique refl. 6279 11127 
Rint 0.0365 0.0642 
R1a (all data) 0.0414 0.0470 
wR2b (all data) 0.0737 0.0700 
R1 [(I > 2)] 0.0341 0.0345 
wR2 [(I > 2)] 0.0699 0.0661 
GOFc 1.148 1.085 
a R1 = ||Fo − |Fc||/|Fo|. 
b wR2 = ((w(Fo
2 − Fc
2)2)/(w(Fo
2)2))1/2. c GOF =  
(w(Fo
2 − Fc
2)2/(n − p))1/2 where n is the number of data and p is the number 
of parameters refined. 
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Figure S1. HMBC spectrum for methoxycarbonyl complex 8, with 1H chemical 
shift on the horizontal axis and 13C chemical shift on the vertical axis. The 
correlation between the methoxycarbonyl 1H and 13C resonances is highlighted with 
an arrow.  
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Figure S2. Plot of the ratio [10]/[4] present at equilibrium when complex 4 (6.0 mM) is treated 
with varying concentrations of CH3OH (●, blue) or CH3OD (■, red). The best-fit lines, which 
were used to determine Keq, are shown as solid lines of the same color. 
 
Figure S3. Partial variable-temperature 1H NMR spectra for complex 4 in the presence of 0.60 
M CH3OH in CD3CN. The cyclopentadienyl region is shown, with peaks attributed to 4 and 10 
labeled. 
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Figure S4. Plot of the ratio [8][LutH+]/[Re-Cp*][Lut] (LutH+ = 2,6-lutidinium, Lut = 2,6-
lutidine, Re-Cp* = [Re(5-Cp*)(CO)2(NO)]+) present at equilibrium when  [Re(5-
Cp*)(CO)2(NO)](BF4) (6.5 mM) is treated with varying concentrations of CH3OH in the 
presence of 2,6-lutidine (ca. 6.5 mM) in CD3CN. The slope of the best-fit line gives Keq. 
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Figure S5. Plot of the ratio [9][LutH+]/[Re-Cp][Lut] (LutH+ = 2,6-lutidinium, Lut = 2,6-
lutidine, Re-Cp = [Re(5-Cp)(CO)2(NO)]+) present at equilibrium when  [Re(5-
Cp)(CO)2(NO)](BF4) (5.9 mM) is treated with varying concentrations of CH3OH in the 
presence of 2,6-lutidine (ca. 5.5 mM) in CD3CN. The slope of the best-fit line gives Keq. 
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Figure S6. Partial variable-temperature 1H NMR spectra for complex [Re(5-
Cp*)(CO)2(NO)](BF4) (abbreviated [Re-Cp*]) in the presence of 1 equivalent of 2,6-lutidine 
with 0.79 M CH3OH in CD3CN. The upfield region is shown, with peaks attributed to 8, [Re-
Cp*], and the averaged peak for 2,6-lutidine/2,6-lutidinium (Lut/LutH+) labeled. Peaks for the 
OH group of the added methanol are labeled with an asterisk (*). 
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Figure S7. Partial variable-temperature 1H NMR spectra for complex [Re(5-
Cp)(CO)2(NO)](BF4) (abbreviated [Re-Cp]) in the presence of 1 equivalent of 2,6-lutidine with 
0.79 M CH3OH in CD3CN. The downfield region is shown, with peaks attributed to 9, [Re-Cp], 
and the averaged peaks for 2,6-lutidine/2,6-lutidinium (Lut/LutH+) labeled.  
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